医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

CartiHeal Granted Four Patents Covering Agili-C™ Cartilage Regeneration Technology

2014年09月03日 PM08:00
このエントリーをはてなブックマークに追加


 

KFAR SABA, Israel

CartiHeal (2009) Ltd., a privately held medical device company headquartered in Kfar Saba, Israel, announces the issuance of four patents — three in the U.S. and one in Japan — for its proprietary cell-free, off-the-shelf cartilage regeneration technology for patients with injuries to the articular surface of joints.

The three U.S. patents nos. 8,808,725, 8,790,681 and 8,802,115, and the Japanese patent 5536793, describe the use of modified coral scaffolds for the treatment of cartilage and bone defects. These patents cover a wide range of claims including treatment of cartilage and osteochondral defects, osteoarthritis and a variety of joint disorders. The patents relate to the Agili-C™ implant, a bi-phasic, coralline-hyaluronate composite scaffold which has undergone chemical, physical and biological modifications. The implant demonstrated clinical safety and effectiveness in a series of clinical trials, by enhancing regeneration of true hyaline cartilage and subchondral bone.

“These four patents strengthen CartiHeal’s IP portfolio, and position the company at the forefront of innovative technologies in the field of cartilage regeneration,” reports Nir Altschuler, founder and CEO of CartiHeal. “Cartilage regeneration represents one of medicine’s most challenging unmet needs. We are proud to say that CartiHeal and its breakthrough technology are able to meet this challenge.”

About CartiHeal

CartiHeal (2009) Ltd., a privately held medical device company headquartered in Israel, is a pioneer in the field of regenerative medicine. CartiHeal’s CE-marked Agili-C™ implant has shown to promote regeneration of true hyaline cartilage and its subchondral bone, simultaneously without the use of cells, growth factors or other exogenous agents. Agili-C™ represents a significant medical breakthrough and was voted one of the top 10 most exciting Israeli medical-device and pharmaceutical developments to watch for in 2014.

For more information about the company please visit: www.cartiheal.com

CONTACT

CartiHeal
Caty Pearl, +972-54-8081020
Marketing Manager
catyp@pearlcom.co.il

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • AVITA Medical Announces First U.S. Sales of RECELL® System and Commencement of Commercial Shipping
  • PotNetwork Holdings, Inc.在注册成为SEC报告公司之后发布PCAOB经审计和审核的完整财务报表
  • PotNetwork Holdings, Inc.提交Form 10以成为美国证券交易委员会报告公司
  • レスメド初の最小接触面フルフェイスCPAPマスクAirFit F30を米国とカナダで販売開始
  • Foundation Medicine Announces Strategic Collaboration with Major Pharmaceutical Company